BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26296529)

  • 1. The effect of extensive intraoperative peritoneal lavage therapy (EIPL) on stage III B + C and cytology-positive gastric cancer patients.
    Masuda T; Kuramoto M; Shimada S; Ikeshima S; Yamamoto K; Nakamura K; Yoshimatsu S; Urata M; Baba H
    Int J Clin Oncol; 2016 Apr; 21(2):289-294. PubMed ID: 26296529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive intraperitoneal lavage to eliminate intraperitoneal tumor cells in gastrectomy with D2 lymphadenectomy for gastric cancer.
    Ronellenfitsch U; Ernst K; Mertens C; Trunk MJ; Ströbel P; Marx A; Kienle P; Post S; Nowak K
    Tumori; 2018 Oct; 104(5):361-368. PubMed ID: 30185117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trial.
    Yang HK; Ji J; Han SU; Terashima M; Li G; Kim HH; Law S; Shabbir A; Song KY; Hyung WJ; Kosai NR; Kono K; Misawa K; Yabusaki H; Kinoshita T; Lau PC; Kim YW; Rao JR; Ng E; Yamada T; Yoshida K; Park DJ; Tai BC; So JBY;
    Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):120-127. PubMed ID: 33253659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma.
    Kuramoto M; Shimada S; Ikeshima S; Matsuo A; Yagi Y; Matsuda M; Yonemura Y; Baba H
    Ann Surg; 2009 Aug; 250(2):242-6. PubMed ID: 19638909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnostic staging laparoscopy.
    Yasufuku I; Nunobe S; Ida S; Kumagai K; Ohashi M; Hiki N; Sano T
    Gastric Cancer; 2020 Mar; 23(2):319-327. PubMed ID: 31350702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Surgery and Extensive Intraoperative Peritoneal Lavage vs Surgery Alone for Treatment of Locally Advanced Gastric Cancer: The SEIPLUS Randomized Clinical Trial.
    Guo J; Xu A; Sun X; Zhao X; Xia Y; Rao H; Zhang Y; Zhang R; Chen L; Zhang T; Li G; Xu H; Xu D
    JAMA Surg; 2019 Jul; 154(7):610-616. PubMed ID: 30916742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
    Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
    Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial).
    Misawa K; Mochizuki Y; Sakai M; Teramoto H; Morimoto D; Nakayama H; Tanaka N; Matsui T; Ito Y; Ito S; Tanaka K; Uemura K; Morita S; Kodera Y;
    Br J Surg; 2019 Nov; 106(12):1602-1610. PubMed ID: 31573086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy with S-1 followed by docetaxel for gastric cancer and CY1P0 peritoneal metastasis after relatively curative surgery.
    Kanazawa Y; Kato S; Fujita I; Onodera H; Uchida E
    J Nippon Med Sch; 2013; 80(5):378-83. PubMed ID: 24189356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
    Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
    Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer.
    Yamamoto K; Shimada S; Hirota M; Yagi Y; Matsuda M; Baba H
    Int J Oncol; 2005 Nov; 27(5):1321-8. PubMed ID: 16211228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for cytology-positive gastric cancer.
    Endo S; Ikenaga M; Ohta K; Ueda M; Tsuda Y; Kato R; Itakura H; Matsuyama J; Nishikawa K; Yamada T
    Surg Today; 2019 Jan; 49(1):56-64. PubMed ID: 30167924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study.
    Yamaguchi T; Takashima A; Nagashima K; Terashima M; Aizawa M; Ohashi M; Tanaka R; Yamada T; Kinoshita T; Matsushita H; Ishiyama K; Hosoda K; Yuasa Y; Haruta S; Kakihara N; Nishikawa K; Yunome G; Satoh T; Fukagawa T; Katai H; Boku N
    Gastric Cancer; 2021 May; 24(3):701-709. PubMed ID: 33179192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Extensive Intraperitoneal Lavage for Patients with Gastric Cancer - A Systematic Review and Meta-analysis.
    Najah Q; Abdelrehim AM; Elmallahy M; Alsubayhay A; Alabdallat YJ
    J Gastrointest Cancer; 2024 Mar; 55(1):96-104. PubMed ID: 37750984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended intraoperative peritoneal lavage as prophylactic peritoneal recurrence for locally advanced gastric cancer: a prospective randomized trial.
    Rodríguez-Santiago J; Luna A; Garsot E; Aldeano A; Balagué C; Rada A
    Clin Transl Oncol; 2021 Sep; 23(9):1857-1865. PubMed ID: 33792839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
    Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
    Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2-lymphadenectomy improves the survival of patients with peritoneal cytology-positive gastric cancer.
    Inada T; Ogata Y; Kubota T; Ishihara M; Tomikawa M; Ando J; Ozawa I; Hishinuma S; Shimizu H; Kotake K
    Anticancer Res; 2002; 22(1A):291-4. PubMed ID: 12017305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the intraoperative peritoneal lavage cytology add prognostic information in patients with potentially curative gastric resection?
    Ribeiro U; Safatle-Ribeiro AV; Zilberstein B; Mucerino D; Yagi OK; Bresciani CC; Jacob CE; Iryia K; Gama-Rodrigues J
    J Gastrointest Surg; 2006 Feb; 10(2):170-6, discussion 176-7. PubMed ID: 16455447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Importance of Extensive Intraoperative Peritoneal Lavage as a Promising Method in Patients with Gastric Cancer Showing Positive Peritoneal Cytology Without Overt Peritoneal Metastasis and Other Therapeutic Approaches.
    Ilhan E; Alemdar A; Ureyen O; Bas K
    J Invest Surg; 2017 Oct; 30(5):318-324. PubMed ID: 27806214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis.
    Marutsuka T; Shimada S; Shiomori K; Hayashi N; Yagi Y; Yamane T; Ogawa M
    Clin Cancer Res; 2003 Feb; 9(2):678-85. PubMed ID: 12576435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.